Preliminary Program
Arriving in Mailboxes Soon!
The preliminary program for the iSBTc 23rd Annual Meeting & Associated Programs has been mailed and should be arriving in your mailbox soon.
Watch the program for:
- Full schedules for each activity
- Confirmed faculty listings
- Hotel and travel information
- Abstract and award submission guidelines
- Registration information
- iSBTc membership information
The 23rd Annual Meeting & Associated Programs will be held October 29-November 2, 2008 at the Westin Gaslamp Quarter in San Diego, CA. Registration and abstract submission are now available on the iSBTc web site.
Anti-CTLA-4 Hot Topic Symposium
Added to Program Schedule
Anti-CTLA-4: Issues in Development and Regulatory Approval will be the feature of a Hot Topics Symposium to be held on Sunday, November 2 from 10:30am-12:00pm in conjunction with the 23rd Annual Meeting and Associated Programs. The program will feature invited speakers, a panel discussion/debate and audience questions. There is no fee to attend this session, but registration is required.
Global Regulatory Summit to Feature International Regulatory Experts
Representatives from regulatory agencies in the United States, Europe, Japan, India, Canada and China will unite for iSBTc's Summit on "Global Regulatory Considerations in the Development of Oncology Biologics Products for the Treatment of Cancer". Experts will share perspectives and facilitate discussion.
Date: October 29, 2008
Location: San Diego, CA
Organizers:
Raj K. Puri, MD, PhD (U.S. Food and Drug Administration, CBER)
Ulrich Kalinke, PhD (Paul-Ehrlich Institut, Germany)
For more information, click here.
New Resources Available
on the iSBTc Web Site
The "Related Links" section of the iSBTc web site is newly updated and provides you with several scientific, research and organizational resources. Links for each of the regulatory agencies that will be participating in the iSBTc Global Regulatory Summit from the U.S., Canada, European Union, Germany, India, Japan, P.R. China and Switzerland have been provided. Other links include organizations that iSBTc has collaborated with, such as the Biotherapy Development Association (BDA) and the Clinical Immunology Society (CiS). Scientific resources have also been added for your use. To view these new resources, please click here.